Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01577420 · ClinicalTrials.gov registry record · NA
Reflexology: An Intervention for Advanced Breast Cancer
A NA study of Breast Cancer, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 451
- Enrollment target
- 12
- Study locations
NCT01577420: Completed NA study of Breast Cancer, sponsored by Michigan State University.
NCT01577420 is a NA study of Breast Cancer that has completed, run by Michigan State University. The registered enrollment target is 451 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (84% lower). The trial reports 12 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01577420, a NA study of Breast Cancer, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 451 participants
- Enrollment target
- 12
- Study locations
Study Summary
The aim of this study is to test a complementary therapy intervention (reflexology) that will assist in improving quality of life (QOL) for women undergoing chemotherapy for late stage (III or IV) breast cancer within the context of conventional medical care. Quality of life will be assessed via intermediate indicators: 1) physical indicators (greater physical functioning, lower presence of symptoms) 2) emotional indicators (greater spirituality, lower anxiety, and lower depressive symptomology); and the outcome indicator of quality of life.
Conditions Studied
Interventions
- OTHER Reflexology Sessions
- OTHER Placebo Sessions
Study Locations (12)
Michigan
- Hurley Medical Center - Flint
- GLCI/McLaren - Flint
- St. Joseph Mercy Oakland Hospital - Grand Rapids
- St. Mary's Health Care Center - Grand Rapids
- Great Lakes Cancer Institute (GLCI) MSU - Lansing
- Sparrow Hospital - Lansing
- William Beaumont Hospital - Royal Oak
- William Beaumont Hospital-Troy Campus - Troy
- St. John Macomb - Warren
- Josephine Ford Cancer Care, Henry Ford Hospital - West Bloomfield
Illinois
- Evanston Northwestern - Evanston
- Mt. Clemens - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2005-08 |
| Est. Completion | 2010-08 |
| Phase | NA |
What the finished NCT01577420 record still lists
NCT01577420 is an interventional study that assigns participants to a tested intervention. The registered 451 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Reflexology Sessions is the first listed.
NCT01577420 lists 12 locations in 2 states (Michigan, Illinois).
Frequently Asked Questions
What is clinical trial NCT01577420 about?
NCT01577420 is a clinical study titled "Reflexology: An Intervention for Advanced Breast Cancer". The aim of this study is to test a complementary therapy intervention (reflexology) that will assist in improving quality of life (QOL) for women undergoing chemotherapy for late stage (III or IV) breast cancer within the context of conventional medical care. Quality of life will be assessed via int...
What is the current status of trial NCT01577420?
This trial is currently completed. It is a NA study. The enrollment target is 451 participants. The study started on 2005-08. Estimated completion is 2010-08.
What conditions does trial NCT01577420 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01577420?
The interventions under investigation include: Reflexology Sessions (OTHER), Placebo Sessions (OTHER).
Who is sponsoring clinical trial NCT01577420?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01577420 being conducted?
This trial has 12 study locations across Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01577420's enrollment target sits among peer trials
451 215th of 1224 higher than 1,010 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia